Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18373394
DOI
10.33549/physiolres.931550
PII: 1550
Knihovny.cz E-zdroje
- MeSH
- energetický metabolismus účinky léků MeSH
- fibrilace komor etiologie metabolismus patofyziologie prevence a kontrola MeSH
- hypertenze komplikace farmakoterapie metabolismus patofyziologie MeSH
- kapiláry účinky léků MeSH
- kardiomyocyty účinky léků metabolismus MeSH
- konexin 43 metabolismus MeSH
- krevní tlak účinky léků MeSH
- krysa rodu Rattus MeSH
- kyseliny mastné omega-3 farmakologie MeSH
- modely nemocí na zvířatech MeSH
- myokard enzymologie metabolismus patologie MeSH
- potkani inbrední SHR MeSH
- potravní doplňky * MeSH
- těsný spoj účinky léků metabolismus MeSH
- věkové faktory MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- konexin 43 MeSH
- kyseliny mastné omega-3 MeSH
Hypertension-induced myocardial metabolic, structural and electrophysiological remodeling deteriorates with aging and contributes to both heart failure and occurrence of malignant arrhythmias. It has been shown in clinical trials that n-3 polyunsaturated fatty acids (n-3 PUFA) reduce the incidence of cardiovascular diseases and sudden cardiac death. We investigated the cardioprotective effects of n-3 PUFA in aged spontaneously hypertensive rats (SHR) and possible cellular mechanisms involved. Male and female 14-moth-old SHR were fed with n-3 PUFA (Vesteralens, Norway, 20 mg/day for two months) and compared with untreated SHR. Results showed that n-3 PUFA supplementation led to 1) significant decline of blood pressure; 2) suppression of inducible ventricular fibrillation (VF) by 57 % (male) and 67 % (female), although the arrhythmogenic substrates, like fibrosis, hypertrophy and abnormal gap junctions distribution were not eliminated; 3) preservation of the cardiomyocytes and the integrity of their junctions; 4) enhancement of energetic metabolism enzyme activity; 5) augmentation of capillary density associated with increased alkaline phosphatase and decreased dipeptidyl peptidase-4 (DPP4) activity and 6/ increase in gap junction channel connexin-43 expression. Thus, aged male as well as female SHR benefit from n-3 PUFA supplementation that results in decrease in VF susceptibility, partly due to an improvement of myocardial metabolic state, cardiomyocyte and cell-to-cell junctions integrity and Cx43 up-regulation.
Citace poskytuje Crossref.org